Immunocore Holdings (IMCR) Stock Highlights

34.38 | +1.87%

2024-10-21 02:13:46

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Statistics

Range Today

33 34.97

Volume Today 218.3K

Range 1 Year

29.72 76.98

Volume 1 Year 128.5M

Range 3 Year

18.43 76.98

Volume 3 Year 245.81M

Range 10 Year

18.43 76.98

Volume 10 Year 262.6M

Highlights

Market Capitalization 1.72B (small)

Floating Shares 41.83M

Current Price 34.38

Price To Earnings -30.67

Price To Revenue 4.75

Price To Book 4.79

Earnings Per Share -1.1

Payout Ratio 0%

Performance

Latest +1.87%

1 Month +1.21%

3 Months -12.61%

6 Months -37.59%

1 Year -31.42%

3 Years -9.05%

5 Years -15.28%

10 Years -15.28%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.